novel transcript, antisense to ZFP91 (ENSG00000269570)

ENSG00000269570 encodes a long non-coding RNA (lncRNA) that is transcribed from the DNA strand opposite to the ZFP91 gene. Antisense transcripts such as this are common in the human genome and can regulate the expression, stability, or processing of their overlapping protein-coding sense genes by a variety of mechanisms, such as the recruitment of chromatin modifiers or interference at the transcriptional level. However, there are no published studies specifically characterizing the function, biological activity, or therapeutic relevance of the “novel transcript, antisense to ZFP91.” It is not recognized as a validated therapeutic target, nor are there current drugs, biomarkers, or disease associations tied to this antisense transcript. Its designation as “novel” reflects a lack of standardized nomenclature and functional characterization. This entry is not a protein-coding gene, receptor, enzyme, or other classical drug target. The term “novel transcript” suggests it is uncharacterized and not yet given a standardized gene symbol or common alias in major human gene databases. The designation “antisense to ZFP91” provides its genomic context, but does not name a unique functional entity; it may represent multiple possible splice forms or partially-annotated sequences. This target is best classified as a non-coding natural antisense transcript with unknown function and unknown disease relevance, not a canonical or established therapeutic target.

Other names

ZFP91-AS